The market has been cooling on Morinaga & Co for weeks, with the stock down about 5.7% over the past month and sitting near ¥2,577 into this Q1 2027 release. Yet the headline numbers point to an earnings story that looks steadier than the recent share price would suggest. Revenue in the quarter came in around ¥63.6b and basic earnings per share were about ¥53.09. The trailing P/E of 12.6x still sits below the broader Japan food sector. The real question now is whether investors are fixated on soft sentiment instead of the underlying profitability trend.
Like the steady earnings but cautious about Morinaga&Co trading on a lower P/E than its sector? Take a look at our hand picked 18 high quality undervalued stocks for ideas that combine quality fundamentals with more compelling valuations.
Q1 2027 Earnings Summary
- Revenue, Q1 2027 vs Q1 2026: ¥63,617 million vs. ¥60,253 million (up about 5.6%)
- Net Income, Q1 2027 vs Q1 2026: ¥4,458 million vs. ¥5,046 million (down about 11.7%)
- Basic EPS, Q1 2027 vs Q1 2026: ¥53.09 vs. ¥59.61 (down about 10.9%)
- Trailing Net Profit Margin, last 12 months vs prior year: 7.2% vs. 7.7% (margin compressed by about 0.5 percentage points)
Tired of scrolling through dense earnings tables and raw figures for Morinaga&Co? Get a clear view of the stock's valuation, growth metrics, and key ratios in a visual format with our full company report for Morinaga&Co..
Morinaga bullish story meets mixed earnings reality
For investors looking at Morinaga as a steady consumer staples stock, the top line helps the story. Q1 2027 revenue of ¥63,617 million compares with ¥60,253 million a year earlier, which points to a business still drawing demand across its confectionery and health related ranges. Recent moves into frozen snacks and functional nutrition, such as the My/Mochi deal and a new postbiotic ingredient, support the idea of a broader product base that can help underpin that revenue trend even as individual categories cycle differently.
Profit pressure keeps the cautious Morinaga view alive
The more cautious narrative also has support in these numbers. Q1 2027 net income of ¥4,458 million compares with ¥5,046 million a year earlier and basic EPS moved the same way, which aligns with earlier guidance for softer profit after a record FY2026. Trailing net margin compressed from 7.7% to 7.2%. That indicates cost pressure and mix effects remain real issues even as Morinaga expands into higher value health products and frozen snacks.
Compare Morinaga&Co's push into frozen snacks and health focused products with how the street is reacting to softer margins and a lower P/E, then see whether analysts are leaning toward a rebound or more caution with the consensus price target analysis for Morinaga&Co.Stay Ahead With Simply Wall St
If Morinaga&Co's steady revenue but softer margins have you watching for a better entry point, register for free with Simply Wall St and add it to your Watchlist so you can track price against fair value and key earnings updates in one place. Once you hold the stock, use the Portfolio Command Center to cut through daily noise and focus on the events that really affect your returns. For a broader view of what investors are thinking and how they are reacting to results like Morinaga&Co's Q1 2027 numbers, tap into the Community and see different perspectives side by side. By spotting potential catalysts and risks early, you give yourself more tools to stay informed about the market rather than reacting after it moves.
Curious About Alternatives Beyond Morinaga?
Fresh ideas move quickly. Some stocks are building quiet breakout momentum while others get caught dropping before the crowd even notices. Check these under the radar lists and act now.
- Spot companies building long term compounding stories with strong balance sheets and cash flows using our hand picked list of solid balance sheet and fundamentals stocks (40 results).
- Ride potential income momentum with stocks that aim to keep paying while others pause. Scan our curated 43 dividend fortresses.
- Target future facing infrastructure behind AI growth and data demand before it flies fully onto the radar through a focused shortlist of 56 AI infrastructure stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com